Terms: = Lung cancer AND RUNX1T1, ENSG00000079102, 862 AND Staging
6 results:
1. Diagnostic performance and prognostic value of CT-defined visceral pleural invasion in early-stage lung adenocarcinomas.
Lim WH; Lee KH; Lee JH; Park H; Nam JG; Hwang EJ; Chung JH; Goo JM; Park S; Kim YT; Kim H
Eur Radiol; 2024 Mar; 34(3):1934-1945. PubMed ID: 37658899
[TBL] [Abstract] [Full Text] [Related]
2. Assessment of whole-body MRI including diffusion-weighted sequences in the initial staging of breast cancer patients at high risk of metastases in comparison with PET-CT: a prospective cohort study.
Hottat NA; Badr DA; Ben Ghanem M; Besse-Hammer T; Lecomte SM; Vansteelandt C; Lecomte SL; Khaled C; De Grove V; Salem Wehbe G; Cannie MM; Jani JC
Eur Radiol; 2024 Jan; 34(1):165-178. PubMed ID: 37555959
[TBL] [Abstract] [Full Text] [Related]
3. A nomogram for predicting cause-specific mortality among patients with cecal carcinoma: a study based on SEER database.
Zhou Q; Zhan Y; Guo J
BMC Gastroenterol; 2023 May; 23(1):177. PubMed ID: 37221487
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis.
Mehanna H; Taberna M; von Buchwald C; Tous S; Brooks J; Mena M; Morey F; Grønhøj C; Rasmussen JH; Garset-Zamani M; Bruni L; Batis N; Brakenhoff RH; Leemans CR; Baatenburg de Jong RJ; Klussmann JP; Wuerdemann N; Wagner S; Dalianis T; Marklund L; Mirghani H; Schache A; James JA; Huang SH; O'Sullivan B; Nankivell P; Broglie MA; Hoffmann M; Quabius ES; Alemany L;
Lancet Oncol; 2023 Mar; 24(3):239-251. PubMed ID: 36796393
[TBL] [Abstract] [Full Text] [Related]
5. Results of emergency salvage lung resection after chemo- and/or radiotherapy among patients with lung cancer.
Hino H; Utsumi T; Maru N; Matsui H; Taniguchi Y; Saito T; Tsuta K; Murakawa T
Interact Cardiovasc Thorac Surg; 2022 Jun; 35(1):. PubMed ID: 35253874
[TBL] [Abstract] [Full Text] [Related]
6. Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging α(v)β(3) integrin levels.
Mittra ES; Goris ML; Iagaru AH; Kardan A; Burton L; Berganos R; Chang E; Liu S; Shen B; Chin FT; Chen X; Gambhir SS
Radiology; 2011 Jul; 260(1):182-91. PubMed ID: 21502381
[TBL] [Abstract] [Full Text] [Related]
